{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:32:26Z","timestamp":1793367146346,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K08866"],"award-info":[{"award-number":["JP22K08866"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejso.2026.112035","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:36:45Z","timestamp":1784936205000},"page":"112035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical T classification predicts tumour remnants and prognosis in patients with oesophageal squamous cell carcinoma treated with neoadjuvant docetaxel\/cisplatin\/5-fluorouracil therapy followed by surgery"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1525-5087","authenticated-orcid":false,"given":"Yusuke","family":"Muneoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6515-5316","authenticated-orcid":false,"given":"Hiroshi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7970-7599","authenticated-orcid":false,"given":"Takeo","family":"Bamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1367-7904","authenticated-orcid":false,"given":"Yosuke","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sou","family":"Hiroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5766-272X","authenticated-orcid":false,"given":"Hiroto","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0422-5456","authenticated-orcid":false,"given":"Kazuyasu","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0524-236X","authenticated-orcid":false,"given":"Yoshifumi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4849-5490","authenticated-orcid":false,"given":"Jun","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3972-9889","authenticated-orcid":false,"given":"Takashi","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9033-2508","authenticated-orcid":false,"given":"Hajime","family":"Umezu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7234-5807","authenticated-orcid":false,"given":"Satoru","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2443-3428","authenticated-orcid":false,"given":"Toshifumi","family":"Wakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejso.2026.112035_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2026.112035_bib2","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(02)08651-8","article-title":"Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2026.112035_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"MAGIC trial participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.112035_bib4","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.112035_bib5","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","article-title":"Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial","volume":"36","author":"Yang","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112035_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ags3.12243","article-title":"Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer","volume":"3","author":"Mayanagi","year":"2019","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.ejso.2026.112035_bib7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ags3.12364","article-title":"Role of surgery in multidiscliplinary treatment strategies for locally advanced esophageal squamous cell carcinoma","volume":"4","author":"Saeki","year":"2020","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.ejso.2026.112035_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(24)00745-1","article-title":"Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomized, controlled, open-label, phase 3 trial","volume":"404","author":"Kato","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2026.112035_bib9","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.surg.2010.02.016","article-title":"Utility of response evaluation to neoadjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma","volume":"148","author":"Makino","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2026.112035_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.surg.2008.06.026","article-title":"Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma","volume":"144","author":"Makino","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2026.112035_bib11","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.112035_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1442-2050.2000.00136.x","article-title":"Evaluation of the histologic effect of chemoradiation therapy for squamous cell carcinomas of the esophagus by assessing morphologic features of surgical specimens","volume":"13","author":"Yamamoto","year":"2000","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ejso.2026.112035_bib13","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/SLA.0b013e3182a6191d","article-title":"Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa","volume":"258","author":"Shapiro","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.112035_bib14","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1245\/s10434-015-4412-8","article-title":"A pathological study of residual cancer in the esophageal wall following neoadjuvant chemoradiotherapy: focus on esophageal squamous cell carcinoma patients with false negative preoperative endoscopic biopsies","volume":"22","author":"Chao","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112035_bib15","first-page":"179","volume":"21","author":"Mine","year":"2024"},{"key":"10.1016\/j.ejso.2026.112035_bib16","first-page":"343","volume":"20","author":"Kitagawa","year":"2023"},{"key":"10.1016\/j.ejso.2026.112035_bib17","series-title":"TNM classification of malignant Tumors. International Union against Cancer","year":"2009"},{"key":"10.1016\/j.ejso.2026.112035_bib18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1072-7515(98)00013-1","article-title":"Outcomes of extended radical esophagectomy for thoracic esophageal cancer","volume":"186","author":"Nishimaki","year":"1998","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ejso.2026.112035_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jso.21295","article-title":"Pathological analysis after neoadjuvant chemoradiotherapy for esophageal carcinoma: the Rotterdam experience","volume":"100","author":"Van Meerten","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112035_bib20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000502342","article-title":"Prognostic factors for esophageal squamous cell carcinoma treated with neoadjuvant docetaxel\/cisplatin\/5-fluorouracil followed by surgery","volume":"97","author":"Sugimura","year":"2019","journal-title":"Oncology"},{"key":"10.1016\/j.ejso.2026.112035_bib21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s10388-024-01062-y","article-title":"Response to chemotherapy could predict the prognosis of esophageal squamous cell carcinoma treated with neoadjuvant docetaxel, cisplatin, and fluorouracil (DCF) followed by surgery: long-term results in a single institute","volume":"21","author":"Sato","year":"2024","journal-title":"Esophagus"},{"key":"10.1016\/j.ejso.2026.112035_bib22","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.21873\/anticanres.17596","article-title":"The long-term outcomes of borderline resectable T3 in locally advanced esophageal squamous cell carcinoma treated with neoadjuvant triplet chemotherapy","volume":"45","author":"Kitadani","year":"2025","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2026.112035_bib23","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/s41416-022-01726-5","article-title":"Multicenter randomized trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinoma","volume":"126","author":"Makino","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2026.112035_bib24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/ags3.12706","article-title":"Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer","volume":"7","author":"Wakita","year":"2023","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.ejso.2026.112035_bib25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s12029-020-00431-x","article-title":"Downstaging and histological effects might be reliable predictors of the efficacy of DOC+CDDP+5-FU (DCF) as neoadjuvant therapy for stage III or borderline resectable esophageal cancer: a single institute experience","volume":"52","author":"Kobayashi","year":"2021","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.ejso.2026.112035_bib26","first-page":"3535","article-title":"Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer","volume":"31","author":"Yokota","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2026.112035_bib27","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1007\/s00268-019-05000-3","article-title":"The benefits of docetaxel plus cisplatin and 5-fluorouracil induction therapy in conversion to curative treatment for locally advanced esophageal squamous cell carcinoma","volume":"43","author":"Takeuchi","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2026.112035_bib28","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1007\/s00268-022-06568-z","article-title":"Evaluation of neoadjuvant chemoradiotherapy followed by surgery for borderline resectable esophageal squamous cell carcinoma","volume":"46","author":"Hirohata","year":"2022","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2026.112035_bib29","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1245\/s10434-021-09875-2","article-title":"Comparison of aggressive planned salvage surgery versus neoadjuvant chemoradiotherapy plus surgery for borderline resectable T4 squamous cell carcinoma","volume":"28","author":"Shiraishi","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112035_bib30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/jjco\/hyz112","article-title":"Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE)","volume":"49","author":"Terada","year":"2019","journal-title":"Jpn J Clin Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326006542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326006542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:45:19Z","timestamp":1793364319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326006542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0748798326006542"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112035","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical T classification predicts tumour remnants and prognosis in patients with oesophageal squamous cell carcinoma treated with neoadjuvant docetaxel\/cisplatin\/5-fluorouracil therapy followed by surgery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"112035"}}